These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8267677)

  • 1. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats.
    Matsumoto S; Tagawa M; Hatoyama T; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.
    Fujii T; Tanaka K; Matsumoto S; Hatoyama T; Nomura N; Tagawa M; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):538-43. PubMed ID: 7912072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
    Sakashita M; Mizuki Y; Yamaguchi T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats.
    Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.
    Sakashita M; Yamaguchi T; Miyazaki H; Sekine Y; Nomiyama T; Tanaka S; Miwa T; Harasawa S
    Arzneimittelforschung; 1993 Aug; 43(8):867-72. PubMed ID: 8216445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 3rd communication: tissue accumulation after consecutive oral administration of [N-methyl-14C]-imidapril in rats.
    Yamada Y; Endo M; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):475-82. PubMed ID: 1642670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and metabolism of [14C]sparfloxacin after repeated administration in the rat.
    Matsunaga Y; Miyazaki H; Nomura N; Hashimoto M
    Arzneimittelforschung; 1991 Jul; 41(7):760-3. PubMed ID: 1663355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
    Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
    Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.